Second allogeneic stem cell transplantation can rescue a significant proportion of patients with JMML relapsing after first allograft

Vinci, Luca; Flotho, Christian; Noellke, Peter; Lebrecht, Dirk; masetti, riccardo; de Haas, Valerie; Diaz de Heredia, Cristina

dc.contributor	Vall d'Hebron Barcelona Hospital Campus
dc.contributor.author	Vinci, Luca
dc.contributor.author	Flotho, Christian
dc.contributor.author	Noellke, Peter
dc.contributor.author	Lebrecht, Dirk
dc.contributor.author	masetti, riccardo
dc.contributor.author	de Haas, Valerie
dc.contributor.author	Diaz de Heredia, Cristina
dc.date.accessioned	2023-06-23T11:12:42Z
dc.date.available	2023-06-23T11:12:42Z
dc.date.issued	2023-05
dc.identifier.citation	Vinci L, Flotho C, Noellke P, Lebrecht D, Masetti R, de Haas V, et al. Second allogeneic stem cell transplantation can rescue a significant proportion of patients with JMML relapsing after first allograft. Bone Marrow Transplant. 2023 May;58:607–9.
dc.identifier.issn	1476-5365
dc.identifier.uri	https://hdl.handle.net/11351/9869
dc.description	Myeloproliferative disease; Paediatrics
dc.language.iso	eng
dc.publisher	Springer Nature
dc.relation.ispartofseries	Bone Marrow Transplantation;58
dc.rights	Attribution 4.0 International
dc.rights.uri	http://creativecommons.org/licenses/by/4.0/
dc.source	Scientia
dc.subject	Leucèmia mieloide - Tractament
dc.subject	Cèl·lules mare hematopoètiques - Trasplantació
dc.subject	Al·loempelts
dc.subject.mesh	Leukemia, Myelomonocytic, Juvenile
dc.subject.mesh	Hematopoietic Stem Cell Transplantation
dc.subject.mesh	Transplantation, Homologous
dc.title	Second allogeneic stem cell transplantation can rescue a significant proportion of patients with JMML relapsing after first allograft
dc.type	info:eu-repo/semantics/article
dc.identifier.doi	10.1038/s41409-023-01942-4
dc.subject.decs	leucemia mielomonocítica juvenil
dc.subject.decs	trasplante de células madre hematopoyéticas
dc.subject.decs	trasplante homólogo
dc.relation.publishversion	https://doi.org/10.1038/s41409-023-01942-4
dc.type.version	info:eu-repo/semantics/publishedVersion
dc.audience	Professionals
dc.contributor.organismes	Institut Català de la Salut
dc.contributor.authoraffiliation	[Vinci L, Noellke P, Lebrecht D] Department of Pediatrics and Adolescent Medicine, Division of Pediatric Hematology and Oncology, Medical Center, Faculty of Medicine, University of Freiburg, Freiburg, Germany. [Flotho C] Department of Pediatrics and Adolescent Medicine, Division of Pediatric Hematology and Oncology, Medical Center, Faculty of Medicine, University of Freiburg, Freiburg, Germany. German Cancer Consortium (DKTK), Heidelberg and Freiburg, Freiburg, Germany. [Masetti R] Pediatric Oncology and Hematology, IRCCS Azienda OspedalieroUniversitaria di Bologna, Bologna, Italy. [de Haas V] Princess Maxima Center, Diagnostic Laboratory/DCOG Laboratory, Utrecht, The Netherlands. [Diaz de Heredia C] Unitat de Trasplantament de Progenitors Hematopoètics, Servei d'Hematologia i Oncologia Pediàtriques, Vall d’Hebron Hospital Universitari, Barcelona, Spain
dc.identifier.pmid	36823455
dc.identifier.wos	000938041700001
dc.rights.accessrights	info:eu-repo/semantics/openAccess